Quantitative studies of Epstein-Barr virus-encoded micrornas provide novel insights into their regulation

Journal of Virology

Volumn 85, Issue 2, 2011, Pages 996-1010

  Amoroso, Richard ^a   Fitzsimmons, Leah ^a   Thomas, Wendy A ^a   Kelly, Gemma L ^a   Rowe, Martin ^a   Bell, Andrew I ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BAMHI A RIGHTWARD TRANSCRIPT; MICRORNA; PROTEIN BHRF1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; B LYMPHOCYTE; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; LATENT PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

B-LYMPHOCYTES; CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN HERPESVIRUS 4;

EID: 78650660355     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01528-10     Document Type: Article

References (66)

1. Alfieri, C., M. Birkenbach, and E. Kieff. 1991. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595-608.
2. Allday, M. J., D. H. Crawford, and B. E. Griffin. 1989. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J. Gen. Virol. 70:1755-1764.
3. Al-Mozaini, M., et al. 2009. Epstein-Barr virus BART gene expression. J. Gen. Virol. 90:307-316.
4. Altmann, M., and W. Hammerschmidt. 2005. Epstein-Barr Virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol. 3:e404.
5. Anderton, E., J. Yee, P. Smith, T. Crook, R. E. White, and M. J. Allday. 2008. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27:421-433.
6. Arrand, J. R., and L. Rymo. 1982. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J. Virol. 41:376-389.
7. Austin, P. J., E. Flemington, C. N. Yandava, J. L. Strominger, and S. H. Speck. 1988. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 85:3678-3682.
8. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
9. Barth, S., et al. 2008. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 36: 666-675.
10. Bell, A. I., et al. 2006. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J. Gen. Virol. 87:2885-2890.
11. Bushati, N., and S. M. Cohen. 2007. microRNA functions. Annu. Rev. Cell Dev. Biol. 23:175-205.
12. Cai, X., et al. 2006. Epstein-Barr Virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2:e23.
13. Chen, C., et al. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e179.
14. Chen, H., et al. 2005. Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts. J. Virol. 79:1724-1733.
15. Chen, H., P. Smith, R. F. Ambinder, and S. D. Hayward. 1999. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood 93:3026-3032.
16. Chen, H. L., et al. 1992. Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 191:193-201.
17. Cheung, S. T., et al. 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 83:121.
18. Choy, E. Y., et al. 2008. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 205:2551-2560.
19. Cosmopoulos, K., et al. 2009. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 83:2357-2367.
20. Delecluse, H. J., T. Hilsendegen, D. Pich, R. Zeidler, and W. Hammerschmidt. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U. S. A. 95:8245-8250.
21. Edwards, R. H., A. R. Marquitz, and N. Raab-Traub. 2008. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J. Virol. 82:9094-9106.
22. Fabian, M. R., N. Sonenberg, and W. Filipowicz. 2010. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79:351-379.
23. Fries, K. L., et al. 1997. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J. Virol. 71:2765-2771.
24. Garibal, J., et al. 2007. Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A. J. Virol. 81:7598-7607.
25. Gilligan, K., J. Rajadurai, and J. Lin. 1991. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J. Virol. 65:6252-6259.
26. Gilligan, K., et al. 1990. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J. Virol. 64:4948-4956.
27. Gottwein, E., and B. R. Cullen. 2008. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3:375-387.
28. Gregory, C. D., M. Rowe, and A. B. Rickinson. 1990. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J. Gen. Virol. 71(Pt. 7):1481-1495.
29. Griffiths-Jones, S., H. K. Saini, S. van Dongen, and A. J. Enright. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36:D154-D158.
30. Grundhoff, A., C. S. Sullivan, and D. Ganem. 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12:733-750.
31. Habeshaw, G., Q. Y. Yao, A. I. Bell, D. Morton, and A. B. Rickinson. 1999. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J. Virol. 73:965-975.
32. Hummel, M., and E. Kieff. 1982. Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection. Proc. Natl. Acad. Sci. U. S. A. 79:5698-5702.
33. Hutzinger, R., et al. 2009. Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog. 5:e1000547.
34. Junying, J., et al. 2003. Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma. Virology 306:236-243.
35. Kelly, G., A. Bell, and A. Rickinson. 2002. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat. Med. 8:1098-1104.
36. Kelly, G. L., et al. 2009. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog. 5:e1000341.
37. Kelly, G. L., A. E. Milner, G. S. Baldwin, A. I. Bell, and A. B. Rickinson. 2006. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc. Natl. Acad. Sci. U. S. A. 103:14935-14940.
38. Kelly, G. L., et al. 2005. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J. Virol. 79:10709-10717.
39. Kieff, E., and A. B. Rickinson. 2007. Epstein-Barr virus and its replication, p. 2511. In D. M. Knipe et al. (ed.), Fields virology, 5th ed. Lippincott-Raven, Philadelphia, PA.
40. Kienzle, N., et al. 1998. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J. Virol. 72:6614-6620.
41. Kim do, N., et al. 2007. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J. Virol. 81:1033-1036.
42. Lerner, M. R., N. C. Andrews, G. Miller, and J. A. Steitz. 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 78:805-809.
43. Lewis, B. P., C. B. Burge, and D. P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
44. Lo, A. K., et al. 2007. Modulation of LMP1 protein expression by EBVencoded microRNAs. Proc. Natl. Acad. Sci. U. S. A. 104:16164-16169.
45. Lung, R. W., et al. 2009. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 11:1174-1184.
46. Nonkwelo, C., J. Skinner, A. Bell, A. Rickinson, and J. Sample. 1996. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol. 70:623-627.
47. Pearson, G. R., et al. 1987. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151-161.
48. Pfeffer, S., et al. 2004. Identification of virus-encoded microRNAs. Science 304:734-736.
49. Pratt, Z. L., M. Kuzembayeva, S. Sengupta, and B. Sugden. 2009. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386:387-397.
50. Rea, D., et al. 1994. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors. Ann. Oncol. 5:113-116.
51. Ressing, M. E., et al. 2005. Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. J. Immunol. 174:6829-6838.
52. Rickinson, A. B., and E. Kieff. 2007. Epstein-Barr virus, p. 2655-2700. In D. M. Knipe et al. (ed.), Fields virology, 5th ed., vol. II. Lippincott, Williams & Wilkins, Philadelphia, PA.
53. Sadler, R. H., and N. Raab-Traub. 1995. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J. Virol. 69:1132-1141.
54. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. U. S. A. 92:10565-10569.
55. Seto E Fau-Moosmann, A., et al. 2010. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. Plos Pathog. 6:e1001063.
56. Shannon-Lowe, C., et al. 2005. Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. J. Gen. Virol. 86:3009-3019.
57. Smith, P. R., et al. 2000. Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J. Virol. 74:3082-3092.
58. Swartwout, S. G., and A. J. Kinniburgh. 1989. c-myc RNA degradation in growing and differentiating cells: possible alternate pathways. Mol. Cell. Biol. 9:288-295.
59. Tierney, R. J., et al. 2000. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation. J. Virol. 74: 10468-10479.
60. Xia, T., et al. 2008. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 68:1436-1442.
61. Xing, L., and E. Kieff. 2007. Epstein-Barr virus BHRF1 micro-and stable RNAs during latency III and after induction of replication. J. Virol. 81:9967-9975.
62. Yandava, C. N., and S. H. Speck. 1992. Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity. J. Virol. 66:5646-5650.
63. Young, L., et al. 1989. Expression of Epstein-Barr virus transformationassociated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321:1080-1085.
64. Yuan, J., E. Cahir-McFarland, B. Zhao, and E. Kieff. 2006. Virus and cell RNAs expressed during Epstein-Barr virus replication. J. Virol. 80:2548-2565. (Pubitemid 43271560)
65. Zhu, J. Y., et al. 2009. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J. Virol. 83:3333-3341.
66. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415.